Presentation is loading. Please wait.

Presentation is loading. Please wait.

Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease 

Similar presentations


Presentation on theme: "Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease "— Presentation transcript:

1 Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease  Anthony Lopez, Morgane Mounier, Anne-Marie Bouvier, Fabrice Carrat, Marc Maynadié, Laurent Beaugerie, Laurent Peyrin-Biroulet  Clinical Gastroenterology and Hepatology  Volume 12, Issue 8, Pages (August 2014) DOI: /j.cgh Copyright © 2014 AGA Institute Terms and Conditions

2 Figure 1 Detailed description of 5 cases of MD. RAEB-1, refractory anemias with excess blasts type 1; UIBD, unclassified IBD. Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh ) Copyright © 2014 AGA Institute Terms and Conditions


Download ppt "Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease "

Similar presentations


Ads by Google